Suraksha Diagnostic Ltd is currently held by 7 active mutual funds (excluding ETFs and Index funds) with a total exposure of ₹288.14 Cr. This month 1 fund exited. Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option has the highest allocation at 1.32%, followed by JM Small Cap Fund (Direct) - Growth Option at 1.19%. ↓ Scroll down for full fund list and monthly changes.
| Category | Funds | Avg Weight | Distribution |
|---|---|---|---|
| Equity | 3 | 0.99% | |
| Small Cap | 2 | 0.87% | |
| Balanced Advantage | 1 | 0.30% | |
| ELSS | 1 | 0.32% |
| Fund ↕ | Category ↕ | Weight ↕ | Value ↕ | Change ↕ |
|---|---|---|---|---|
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund |
Equity | 1.32% | ₹110.64 Cr | +0.2% |
| JM Small Cap Fund (Direct) - Growth Option JM Financial Mutual Fund |
Small Cap | 1.19% | ₹8.07 Cr | +0.02% |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth Aditya Birla Sun Life Mutual Fund |
Equity | 1.06% | ₹9.50 Cr | +0.17% |
| Bandhan Innovation Fund - Direct Plan - Growth Bandhan Mutual Fund |
Equity | 0.60% | ₹12.53 Cr | +0.04% |
| Kotak-Small Cap Fund - Growth - Direct Kotak Mutual Fund |
Small Cap | 0.54% | ₹94.12 Cr | +0.05% |
| Aditya Birla Sun Life ELSS Tax Saver Fund - Growth - Direct Plan Aditya Birla Sun Life Mutual Fund |
ELSS | 0.32% | ₹46.56 Cr | +0.04% |
| BANDHAN Balanced Advantage Fund Direct Plan Growth Bandhan Mutual Fund |
Balanced Advantage | 0.30% | ₹6.72 Cr | +0.03% |